Fact CheckerSign in

NCT04315571Completed

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents

Effective Ascites ReLief In earlY TIPS (EARLY TIPS) Using Viatorr CX vs. LVP Study

Source: ClinicalTrials.gov · Last updated 7 Jul 2026

Brief summary (registry, in English)

For this study, the investigators will be collecting data based on patients' random selection to two different approved standard of care treatments for ascites: Subjects will get randomized into either Group A: Large Volume Paracentesis (LVP) with albumin infusion, or Group B: an early transjugular intrahepatic portosystemic shunt (TIPS) procedure.

Status (registry)
Completed
Study type
Interventional
Enrollment
68 (actual)
First submitted
9 Mar 2020
Start date
24 Mar 2020
Primary completion date
1 Apr 2026
Lead sponsor
University of California, Los Angeles
NCT number
NCT04315571

What you commit to

  • Study type: Interventional
  • Participants enrolled: 68
  • From 24 Mar 2020 to the primary completion date, 1 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Liver failure (Child Pugh \> 12)
  • Cardiac failure
  • Absolute TIPS contraindications (e.g. right heart failure, severe encephalopathy, liver failure, pregnant (if possible)).

Age

  • Age \<18

Other

  • LVP \> 6 times in 2 months
  • No right jugular venous access

Who the study is looking for

  • Males and females \> 18 years of age at time of procedure
  • First de novo TIPS placement
  • Patent internal or external jugular vein
  • Willing to provide the hepatology service information for follow up
  • No known diagnosis of hypercoagulopathy
  • No portal vein thrombosis
  • No malignancy (must be a definite diagnosis)
  • Patient must provide written informed consent
  • Proper clinical indication of TIPS based on American Association for the Study of Liver Diseases (AASLD) guidelines
    • Recurrent ascites necessitating at least 2 large volume paracenteses performed within a minimum interval of 3 weeks

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UCLA Medical Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.